Results     25-Apr-24
Analysis
LTIMindtree
Net profit down 1.2% YoY to Rs 1099.9 cr in Q4FY2024
On consolidated basis

Quarter ended March 2024 compared with Quarter ended December 2023.

Net sales (including other operating income) of LTIMindtree has declined 1.37% to Rs 8892.9 crore.  

Operating profit margin has declined from 17.58% to 17.27%, leading to 3.10% decline in operating profit to Rs 1,535.70 crore.  Employee cost increased from 62.47% to 65.45%.   Other expenses fell from 19.95% to 17.28%.   Expenses from contract fell from 7.23% to 6.70%.   

Other income fell 5.42% to Rs 207.6 crore.  PBIDT fell 3.39% to Rs 1743.3 crore.  Provision for interest rose 12.03% to Rs 68 crore.  Loan funds remained nil.  

PBDT fell 3.92% to Rs 1675.3 crore.  Provision for depreciation rose 14.07% to Rs 227 crore.  

Profit before tax down 6.24% to Rs 1,448.30 crore.  Share of profit/loss were nil in both the periods.  Provision for tax was expense of Rs 347.6 crore, compared to Rs 375.4 crore.  Effective tax rate was 24.00% compared to 24.30%.

Minority interest increased 100% to Rs 0.80 crore.  Net profit attributable to owners of the company decreased 5.90% to Rs 1,099.90 crore.  

Promoters’ stake was 68.60% as of 31 March 2024 ,compared to 68.64% as of 31 December 2023 .  


Quarter ended March 2024 compared with Quarter ended March 2023.

Net sales (including other operating income) of LTIMindtree has increased 2.32% to Rs 8892.9 crore.  Sales of Banking Financial Services segment has gone down 5.38% to Rs 3,121.80 crore (accounting for 35.10% of total sales).  Sales of Manufacturing segment has gone up 8.55% to Rs 1,653.40 crore (accounting for 18.59% of total sales).  Sales of High Tech Media & Entertainment segment has gone up 8.20% to Rs 2,162.80 crore (accounting for 24.32% of total sales).  Sales of CPG Retail Pharma segment has gone up 0.61% to Rs 1,342.70 crore (accounting for 15.10% of total sales).  Sales of Health & Public Services segment has gone up 14.37% to Rs 612.20 crore (accounting for 6.88% of total sales).  

Profit before interest, tax and other unallocable items (PBIT) has slumped 4.24% to Rs 1,535.70 crore.  PBIT of Banking Financial Services segment fell 17.06% to Rs 487.70 crore (accounting for 31.76% of total PBIT).  PBIT of Manufacturing segment fell 3.69% to Rs 258.60 crore (accounting for 16.84% of total PBIT).  PBIT of High Tech Media & Entertainment segment rose 6.43% to Rs 436.70 crore (accounting for 28.44% of total PBIT).  PBIT of CPG Retail Pharma segment fell 6.98% to Rs 242.60 crore (accounting for 15.80% of total PBIT).  PBIT of Health & Public Services segment rose 44.68% to Rs 110.10 crore (accounting for 7.17% of total PBIT).  

PBIT margin of Banking Financial Services segment fell from 17.82% to 15.62%.  PBIT margin of Manufacturing segment fell from 17.63% to 15.64%.  PBIT margin of High Tech Media & Entertainment segment fell from 20.53% to 20.19%.  PBIT margin of CPG Retail Pharma segment fell from 19.54% to 18.07%.  PBIT margin of Health & Public Services segment rose from 14.22% to 17.98%.  Overall PBIT margin fell from 18.45% to 17.27%.  

Operating profit margin has declined from 18.45% to 17.27%, leading to 4.24% decline in operating profit to Rs 1,535.70 crore.  Employee cost increased from 64.21% to 65.45%.   Other expenses fell from 17.34% to 17.28%.   Expenses from contract fell from 7.71% to 6.70%.   

Other income rose 212.65% to Rs 207.6 crore.  PBIDT rose 4.38% to Rs 1743.3 crore.  Provision for interest rose 55.96% to Rs 68 crore.  Loan funds rose to Rs 2,070.60 crore as of 31 March 2024 from Rs 1,541.20 crore as of 31 March 2023.  Inventories declined from Rs 3.30 crore as of 31 March 2023 to Rs 3.00 crore as of 31 March 2024.  Sundry debtors were higher at Rs 5,706.00 crore as of 31 March 2024 compared to Rs 5,623.40 crore as of 31 March 2023.  Cash and bank balance declined from Rs 2,932.00 crore as of 31 March 2023 to Rs 2,816.00 crore as of 31 March 2024.  Investments rose to Rs 8,743.60 crore as of 31 March 2024 from Rs 5,458.30 crore as of 31 March 2023 .  

PBDT rose 3% to Rs 1675.3 crore.  Provision for depreciation rose 24.52% to Rs 227 crore.  Fixed assets increased to Rs 4,338.80 crore as of 31 March 2024 from Rs 3,392.20 crore as of 31 March 2023.  Intangible assets increased from Rs 1,189.20 crore to Rs 1,192.70 crore.  

Profit before tax grew 0.28% to Rs 1,448.30 crore.  Share of profit/loss were nil in both the periods.  Provision for tax was expense of Rs 347.6 crore, compared to Rs 330.1 crore.  Effective tax rate was 24.00% compared to 22.86%.

Minority interest increased 100% to Rs 0.80 crore.  Net profit attributable to owners of the company decreased 1.24% to Rs 1,099.90 crore.  

Equity capital stood at Rs 29.60 crore as of 31 March 2024 to Rs 29.60 crore as of 31 March 2023.  Per share face Value remained same at Rs 1.00.  

Promoters’ stake was 68.60% as of 31 March 2024 ,compared to 68.68% as of 31 March 2023 .  

For year-to-date (YTD) results analysis.

Net sales (including other operating income) of L&T Technology Services has increased 10.32% to Rs 7109.7 crore.  Sales of Transportation segment has gone up 14.84% to Rs 2,350.00 crore (accounting for 33.05% of total sales).  Sales of Process Engineering segment has gone up 5.27% to Rs 994.60 crore (accounting for 13.99% of total sales).  Sales of Industrial Products segment rose 10.08% to Rs 1,234.40 crore (accounting for 17.36% of total sales).  Sales of Medical Devices segment has gone up 11.74% to Rs 724.20 crore (accounting for 10.19% of total sales).  Sales of Telecom segment has gone up 7.26% to Rs 1,806.50 crore (accounting for 25.41% of total sales).  

Profit before interest, tax and other unallocable items (PBIT) has jumped 7.76% to Rs 1,473.30 crore.  PBIT of Transportation segment rose 11.30% to Rs 458.00 crore (accounting for 31.09% of total PBIT).  PBIT of Process Engineering segment rose 2.00% to Rs 255.40 crore (accounting for 17.34% of total PBIT).  PBIT of Industrial Products segment rose 10.10% to Rs 369.60 crore (accounting for 25.09% of total PBIT).  PBIT of Medical Devices segment rose 8.39% to Rs 222.20 crore (accounting for 15.08% of total PBIT).  PBIT of Telecom segment rose 2.13% to Rs 168.10 crore (accounting for 11.41% of total PBIT).  

PBIT margin of Transportation segment fell from 20.11% to 19.49%.  PBIT margin of Process Engineering segment fell from 26.50% to 25.68%.  PBIT margin of Industrial Products segment rose from 29.94% to 29.94%.  PBIT margin of Medical Devices segment fell from 31.63% to 30.68%.  PBIT margin of Telecom segment fell from 9.77% to 9.31%.  Overall PBIT margin fell from 21.21% to 20.72%.  

Operating profit margin has jumped from 19.87% to 19.92%, leading to 10.58% rise in operating profit to Rs 1,416.10 crore.  Employee cost decreased from 53.47% to 52.19%.   Other expenses rose from 26.66% to 27.89%.   

Other income fell 1.05% to Rs 151.3 crore.  PBIDT rose 9.34% to Rs 1567.4 crore.  Provision for interest rose 14.24% to Rs 37.7 crore.  

PBDT rose 9.23% to Rs 1529.7 crore.  Provision for depreciation rose 11.36% to Rs 197 crore.  

Profit before tax grew 8.92% to Rs 1,332.70 crore.  Share of profit/loss were nil in both the periods.  Provision for tax was expense of Rs 367.9 crore, compared to Rs 348.6 crore.  Effective tax rate was 27.61% compared to 28.49%.

Minority interest decreased 30% to Rs 2.10 crore.  Net profit attributable to owners of the company increased 10.40% to Rs 962.70 crore.  

Promoters’ stake was 73.75% as of 31 December 2023 ,compared to 73.85% as of 31 December 2022 .  


Full year results analysis.

Net sales (including other operating income) of LTIMindtree has increased 7.03% to Rs 35517 crore.  Sales of Banking Financial Services segment has gone up 4.83% to Rs 12,840.60 crore (accounting for 36.15% of total sales).  Sales of Manufacturing segment has gone up 17.40% to Rs 6,587.50 crore (accounting for 18.55% of total sales).  Sales of High Tech Media & Entertainment segment has gone up 4.12% to Rs 8,398.70 crore (accounting for 23.65% of total sales).  Sales of CPG Retail Pharma segment has gone up 4.77% to Rs 5,356.00 crore (accounting for 15.08% of total sales).  Sales of Health & Public Services segment has gone up 8.86% to Rs 2,334.20 crore (accounting for 6.57% of total sales).  

Profit before interest, tax and other unallocable items (PBIT) has jumped 4.58% to Rs 6,387.40 crore.  PBIT of Banking Financial Services segment fell 0.61% to Rs 2,162.10 crore (accounting for 33.85% of total PBIT).  PBIT of Manufacturing segment rose 14.06% to Rs 1,015.40 crore (accounting for 15.90% of total PBIT).  PBIT of High Tech Media & Entertainment segment rose 8.56% to Rs 1,870.30 crore (accounting for 29.28% of total PBIT).  PBIT of CPG Retail Pharma segment fell 0.04% to Rs 1,003.10 crore (accounting for 15.70% of total PBIT).  PBIT of Health & Public Services segment rose 6.55% to Rs 336.50 crore (accounting for 5.27% of total PBIT).  

PBIT margin of Banking Financial Services segment fell from 17.76% to 16.84%.  PBIT margin of Manufacturing segment fell from 15.87% to 15.41%.  PBIT margin of High Tech Media & Entertainment segment rose from 21.36% to 22.27%.  PBIT margin of CPG Retail Pharma segment fell from 19.63% to 18.73%.  PBIT margin of Health & Public Services segment fell from 14.73% to 14.42%.  Overall PBIT margin fell from 18.41% to 17.98%.  

Operating profit margin has declined from 18.41% to 17.98%, leading to 4.58% rise in operating profit to Rs 6,387.40 crore.  Employee cost increased from 62.92% to 64.00%.   Other expenses fell from 18.67% to 18.01%.   Expenses from contract fell from 8.52% to 7.21%.   

Other income rose 26.04% to Rs 701.9 crore.  PBIDT rose 6.37% to Rs 7089.3 crore.  Provision for interest rose 47.41% to Rs 221.7 crore.  Loan funds rose to Rs 2,070.60 crore as of 31 March 2024 from Rs 1,541.20 crore as of 31 March 2023.  Inventories declined from Rs 3.30 crore as of 31 March 2023 to Rs 3.00 crore as of 31 March 2024.  Sundry debtors were higher at Rs 5,706.00 crore as of 31 March 2024 compared to Rs 5,623.40 crore as of 31 March 2023.  Cash and bank balance declined from Rs 2,932.00 crore as of 31 March 2023 to Rs 2,816.00 crore as of 31 March 2024.  Investments rose to Rs 8,743.60 crore as of 31 March 2024 from Rs 5,458.30 crore as of 31 March 2023 .  

PBDT rose 5.43% to Rs 6867.6 crore.  Provision for depreciation rose 13.31% to Rs 818.9 crore.  Fixed assets increased to Rs 4,338.80 crore as of 31 March 2024 from Rs 3,392.20 crore as of 31 March 2023.  Intangible assets increased from Rs 1,189.20 crore to Rs 1,192.70 crore.  

Profit before tax grew 4.44% to Rs 6,048.70 crore.  Share of profit/loss were nil in both the periods.  Provision for tax was expense of Rs 1464.1 crore, compared to Rs 1381.2 crore.  Effective tax rate was 24.21% compared to 23.85%.

Minority interest increased 25% to Rs 2.50 crore.  Net profit attributable to owners of the company increased 3.94% to Rs 4,582.10 crore.  

Equity capital stood at Rs 29.60 crore as of 31 March 2024 to Rs 29.60 crore as of 31 March 2023.  Per share face Value remained same at Rs 1.00.  

Promoters’ stake was 68.60% as of 31 March 2024 ,compared to 68.68% as of 31 March 2023 .  

Cash flow from operating activities increased to Rs 5,669.50 crore for year ended March 2024 from Rs 3,094.60 crore for year ended March 2023.  Cash flow used in acquiring fixed assets during the year ended March 2024 stood at Rs 843.20 crore, compared to Rs 939.30 crore during the year ended March 2023.  

 

Dividend: The Board of Directors at its meeting held on April 24, 2024 has declared a final dividend of Rs 45/- per equity share of par value Rs  1/- each.

 

Management Comment:

 

Commenting on the performance of the company Mr. Debashis Chatterjee, Chief Executive Officer and Managing Director, LTIMindtree, said: “We closed FY24 amidst a tough macro environment and delivered a resilient performance with full-year revenue growth of 4.4% in USD terms and an EBIT margin of 15.7%. Our order inflow for the full year at USD 5.6 billion registered a 15.7% growth over FY23. This growth reflects the positive outcomes of our positioning as an organization with scale, expanded capabilities, and larger partnerships. As the market dynamics evolve, we are excited to be part of innovations, partnerships, and initiatives that our clients will embark on in FY 25



LTIMindtree : Consolidated Results
 Quarter endedYear ended
Particulars202403202303Var.(%)202403202303Var.(%)
Net Sales (including other operating income)8,892.908,691.002.3235,517.0033,183.007.03
OPM (%)17.2718.45-118 bps17.9818.41-42 bps
OP1,535.701,603.70-4.246,387.406,107.704.58
Other Inc.207.6066.40212.65701.90556.9026.04
PBIDT1,743.301,670.104.387,089.306,664.606.37
Interest68.0043.6055.96221.70150.4047.41
PBDT1,675.301,626.503.006,867.606,514.205.43
Depreciation227182.324.52818.9722.713.31
PBT1,448.301,444.200.286048.75791.54.44
Share of Profit/(Loss) from Associates00-00-
PBT before EO1448.31444.20.286048.75791.54.44
EO Income00-00-
PBT after EO1448.31444.20.286048.75791.54.44
Taxation347.6330.15.301464.11381.26.00
PAT1100.71114.1-1.204584.64410.33.95
Minority Interest (MI)0.80.4100.002.5225.00
Net profit1099.91113.7-1.244582.14408.33.94
P/(L) from discontinued operations net of tax00-00-
Net profit after discontinued operations1099.91113.7-1.244582.14408.33.94
EPS (Rs)*37.1437.60-1.24154.72148.853.94
* EPS is on current equity of Rs 29.62 crore, Face value of Rs 1, Excluding extraordinary items.
# EPS is not annualised
bps : Basis points
EO : Extraordinary items
Figures in Rs crore
Source: Capitaline Corporate Database


LTIMindtree : Consolidated Segment Results
 Quarter endedYear ended
% of (Total)202403202303Var.(%)% of (Total)202403202303Var.(%)
Sales
Banking Financial Services35.103,121.803,299.20-5.3836.1512,840.6012,249.404.83
Manufacturing18.591,653.401,523.108.5518.556,587.505,611.0017.40
Energy & Utilities0.000.000.00-
High Tech Media & Entertainment24.322,162.801,998.808.2023.658,398.708,066.104.12
CPG Retail Pharma15.101,342.701,334.600.6115.085,356.005,112.304.77
Health & Public Services6.88612.20535.3014.376.572,334.202,144.208.86
Total Reported Sales100.008,892.908,691.002.32100.0035,517.0033,183.007.03
Less: Inter segment revenues 0.000.00- 0.000.00-
Net Sales100.008,892.908,691.002.32100.0035,517.0033,183.007.03
PBIT
Banking Financial Services31.76487.70588.00-17.0633.852,162.102,175.40-0.61
Manufacturing16.84258.60268.50-3.6915.901,015.40890.2014.06
Energy & Utilities0.000.000.00-
High Tech Media & Entertainment28.44436.70410.306.4329.281,870.301,722.808.56
CPG Retail Pharma15.80242.60260.80-6.9815.701,003.101,003.50-0.04
Health & Public Services7.17110.1076.1044.685.27336.50315.806.55
Total PBIT100.001,535.701,603.70-4.24100.006,387.406,107.704.58
Less : Interest68.0043.6055.96221.70150.4047.41
Add: Other un-allcoable-19.40-115.9083.26-117.00-165.8029.43
PBIT Margin(%)
Banking Financial Services 15.6217.82-220.01 16.8417.76-92.12
Manufacturing 15.6417.63-198.80 15.4115.87-45.12
Energy & Utilities 0.000.000.00
High Tech Media & Entertainment 20.1920.53-33.59 22.2721.3691.04
CPG Retail Pharma 18.0719.54-147.34 18.7319.63-90.06
Health & Public Services 17.9814.22376.80 14.4214.73-31.20
PBT100.001,448.301,444.200.28100.006,048.705,791.504.44
Previous News
  LTIMindtree introduces Composable Storefront Quick Launch on Salesforce
 ( Corporate News - 10-Apr-24   14:46 )
  LTIMindtree fixes record date for interim dividend
 ( Market Beat - Reports 18-Oct-23   18:12 )
  LTIMindtree reports PAT of Rs 1,169 cr in Q3 FY24
 ( Hot Pursuit - 17-Jan-24   17:49 )
  LTIMindtree consolidated net profit rises 16.83% in the December 2023 quarter
 ( Results - Announcements 17-Jan-24   17:24 )
  LTIMindtree grants 2,672 stock options under ESOS
 ( Corporate News - 17-Jan-24   14:48 )
  LTI Mindtree grants 4272 stock options under ESOS
 ( Corporate News - 27-Apr-23   15:17 )
  LTIMindtree Ltd rises for third consecutive session
 ( Hot Pursuit - 16-May-24   13:05 )
  LTIMindtree consolidated net profit declines 2.25% in the September 2023 quarter
 ( Results - Announcements 19-Oct-23   07:44 )
  LTIMindtree Ltd soars 1.9%, up for third straight session
 ( Hot Pursuit - 07-Aug-23   13:05 )
  LTIMindtree to hold board meeting
 ( Corporate News - 04-Jul-23   10:15 )
  Nucleus Software Exports Ltd Falls 3.43%, S&P BSE IT Sector index Drops 1.13%
 ( Hot Pursuit - 30-Sep-22   09:45 )
Other Stories
  Apollo Hospitals Enterprise
  04-Jun-24   10:04
  ITL Industries
  01-Jun-24   02:14
  International Combustion (India)
  31-May-24   11:32
  Fluidomat
  31-May-24   11:28
  ISGEC Heavy Engineering
  31-May-24   11:24
  Sreeleathers
  31-May-24   11:20
  Cummins India
  31-May-24   11:18
  Bata India
  31-May-24   09:55
  Tata Steel
  31-May-24   08:36
  India Nippon Electricals
  31-May-24   07:03
Back Top